NURECA
Back to All Ratios
|
NURECA Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| ROCE(%) | 1.31 | -1.06 | -5.17 | 33.57 | 67.61 |
What is the latest Return on Capital Employed (ROCE) ratio of NURECA ?
The latest Return on Capital Employed (ROCE) ratio of NURECA is 1.31 based on Mar2025 Consolidated results.
| Year | Return on Capital Employed (ROCE) |
|---|---|
| Mar2025 | 1.31 |
| Mar2024 | -1.06 |
| Mar2023 | -5.17 |
| Mar2022 | 33.57 |
| Mar2021 | 67.61 |
How is Return on Capital Employed (ROCE) of NURECA Trending?
| Years | Return on Capital Employed (ROCE) | % Change | |
|---|---|---|---|
| Mar2025 | 1.31 | Positive | |
| Mar2024 | -1.06 | Negative | |
| Mar2023 | -5.17 | Negative | |
| Mar2022 | 33.57 | -50.35 | |
| Mar2021 | 67.61 | - | |
Other Financial Ratios of NURECA
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of NURECA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NURECA | ₹217.4 Cr | -8.1% | -21.5% | 1.4% | Stock Analytics | |
| POLY MEDICURE | ₹12,603.5 Cr | -2.8% | -1.1% | -46.4% | Stock Analytics | |
NURECA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NURECA | -8.1% |
-21.5% |
1.4% |
| SENSEX | -2.6% |
-10.2% |
-1.6% |
You may also like the below Video Courses
